Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | Updates in melanoma at ESMO 2023

Marco Donia • 23 Oct 2023
ESMO 2023
Melanoma Skin Cancer

Marco Donia, MD, PhD, Copenhagen University Hospital, Herlev, Denmark, provides an overview of his highlights from the European Society for Medical Oncology (ESMO) 2023 Congress in the field of melanoma, such as neoadjuvant vaccines. Additional updates include novel treatment approaches in brain metastases, mucosal and uveal melanoma. This interview took place at the ESMO 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Marco Donia

0:36
Total tumor volume is predictive of patient response to immunotherapy
Marco Donia • 23 Nov 2023
0:43
Multicolor immunofluorescence to predict melanoma immunotherapy responses
Marco Donia • 22 Oct 2023
0:57
Multiparametric MRI for predicting immunotherapy response in melanomas
Marco Donia • 23 Oct 2023
0:42
Predicting clinical outcomes after immunotherapy
Marco Donia • 23 Oct 2023

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals